Abstract
The feasibility of transplanting kidneys is a tremendous step forward in the treatment of uremic patients, but like all other medical conquests it has its price; one of the drawbacks is the risk of cancer. The theory that cancer arises in conditions of reduced immune capacity in the host was first put forward by Thomas (1959) and later developed in the theory of immune surveillance by Burnet (1964). Since then the theory has been supported by observations made in animal experiments and in reports from human clinical medicine involving patients with immune deficiencies, patients undergoing immunosuppressive treatment, and patients who have undergone kidney transplantation.
This study has been supported by Olga og Esper Boels Fond, A/S Fehr og Co’s Fond, Arvid Nilssons Fond, Ingenioer N.M. Knudsens Fond, Koebmand Sven Hansen og Hustru Ina Hansens Fond, Fonden af 1870, Familien Hede Nielsens Fond, Direktoer E. Danielsen og hustrus Fond, Mads Clausens Fond and S & W Fondet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Barnes BA, Bergan JJ, Braun WE et al. (1977) The 13th report of the human renal transplant registry. Transplant Proc 9:9–26
Birkeland SA (1982) The fate of kidney transplanted patients with a previous history of malignancy. The Scandinavian material. Scand J Urol Nephrol 16:283–286
Birkeland SA (1983a) Cancer in cadaver kidney transplant patients. Surgery 93:504–507
Birkeland SA (1983b) Malignant tumours in renal transplant patients. The Scandia-transplant material. Cancer 51:1571–1575
Birkeland SA (1983c) Chronic antigenic stimulation from the graft as a possible oncogenic factor after renal transplantation. Scand J Urol Nephrol 17:35–39
Birkeland SA (1983d) Cancer in transplanted patients. The Scandiatransplant material. Transplant Proc 15:1071–1078
Birkeland SA (1985) Immune monitoring of tumour development after renal transplantation. Cancer 55:988–994
Birkeland SA (1987) Common aspects on immunological tolerance in pregnancy, transplantation and cancer. In: Birkeland SA et al. (eds) Per aspera ad astra. Birkeland, Odense, Denmark, pp 74–87
Birkeland SA et al. (1973) Malignant tumours following immunosuppression in renal transplantation. Proc EDTA 10:429–433
Birkeland SA, Hauge M et al. (1975) Renal transplantation and cancer, the Scandia-transplant material. Tissue Antigens 6:28–36
Birkeland SA, Hauge M et al. (1977) Cancer as a late-onset complication of kidney transplantation. Scand J Urol Nephrol (suppl) 42:179–183
Birkeland SA, Hauge M et al. (1980) Renal transplantation and cáncer in Scandia-transplant material. Scand J Urol Nephrol (suppl) 54:11–15
Burnet FM (1964) Immunological factors in the process of carcinogenesis. Br Med Bull 20:154–158
Haukulinen T, Andersen AA, Malker B, Pukkala E, Schou G, Tulinius H (1986) Trends in cancer incidence in the nordic countries. A Collaborative study of the five nordic cancer registries. APMIS Sect A (suppl 288) 288:1–151
Hoover R, Fraumeni JF (1973) Risk of cancer in renal-transplant recipients. Lancet ii: 55–57
Lynge E, Holm N (1989) Cancerepidemiologi, Mânedskr Prakt Lægeger 67: 733–784
Penn I (1975) The incidence of malignancies in transplant recipients. Transplant Proc 7:323–326
Peen I (1978a) Development of cancer in transplantation patients. Adv Surg 12:155–191
Penn I (1978b) Immunosuppression and malignant disease. In: Twomey JJ, Good RA (eds) The immunopathology of lymphoreticular neoplasms. Comprehensive Immunology, NY, pp 223–237
Penn I (1981) Malignant lymphomas in organ transplant recipients. Transplant Proc 13:736–738
Penn I (1986) Cancer is a complication in severe immunosuppression. Surg Gynecol Obstet 162:603–610
Penn I (1988) Cancer after cyclosporine therapy. Transplant Proc 20:276–279
Penn I (1989) Risk of cancer in the transplant patient. In: Flye MW (ed) Principles of organ transplantation. Saunders, Philadelphia, pp 634–643
Penn I, Brunson ME (1988) Cancer after cyclosporine therapy 20:885–892
Penn I, Starzl TE (1973) The effect of immunosuppression on cancer. Seventh Natl Cancer Conf Proc Lippincott, Philadelphia, pp 425–436
Penn I, Hammond W, Brettschneider L, Starzl TE (1969) Malignant lymphomas in transplanted patients. Transplant Proc 1:106–112
Polson RJ, Neuberger J, Forman D, Calne R, Williams R (1988) De novo malignancies after liver transplantation. Transplant Proc 20:94–97
Sheil AGR (1986) Cancer after transplantation. World J Surg 10:389–396
Sheil AGR, Mahoney JF, Horvath JS, Johnson JR, Tiller DJ, May J, Stewart JH (1979) Cancer and survival after cadaveric donor renal transplantation. Transplant Proc 11:1052–1054
Sheil AGR, Mahoney JF, Horvath JS, Johnson JR, Tiller DJ, Stewart JH, May J (1981) Cancer following successful cadaveric donor renal transplantation. Transplant Proc 13:733–735
Starzl TE, Groth C-G, Brettschneider L, Smith GV, Penn I, Kashiwagi N (1968) Perspectives in organ transplantation. Antibiot Chemother (Basel) 15:349
Storm HH, Sprøgel P, Bang S, Jensen OM (1989) Cancer incidence in Denmark 1986. Danish Cancer Society, Danish Cancer incidence in Denmark 1986. Danish Cancer Society, Danish Cancer Registry. Danish Cancer Society. Copenhagen
Thomas L (1959) Discussion. Cellular and humoral aspects of the hypersensitive states. Lawrence HS (ed) Hoeber-Harper, New York, p 529
Waterhouse J, Muir C, Correa P, Powell J (1976) Cancer incidence in five continents. Vol 3 IARC Scientific Publications No. 15. International Agency for Research on Cancer, Lyons
Weintraub J, Warnke RA (1982) Lymphoma in cardiac allotransplant recipients. Transplantation 33:347–351
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Birkeland, S.A. (1991). The Nordic Project on Renal Transplantation and Cancer. In: Schmähl, D., Penn, I. (eds) Cancer in Organ Transplant Recipients. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75991-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-75991-8_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53020-6
Online ISBN: 978-3-642-75991-8
eBook Packages: Springer Book Archive